Literature DB >> 20728491

The mechanisms of tolerance in antidepressant action.

Giovanni A Fava1, Emanuela Offidani.   

Abstract

There is increasing awareness that, in some cases, long-term use of antidepressant drugs (AD) may enhance the biochemical vulnerability to depression and worsen its long-term outcome and symptomatic expression, decreasing both the likelihood of subsequent response to pharmacological treatment and the duration of symptom-free periods. A review of literature suggesting potential side effects during long treatment with antidepressant drugs was performed. Studies were identified electronically using the following databases: Medline, Cinahl, PsychInfo, Web of Science and the Cochrane Library. Each database was searched from its inception date to April 2010 using "tolerance", "withdrawal", "sensitization", "antidepressants" and "switching" as key words. Further, a manual search of the psychiatric literature has been performed looking for articles pointing to paradoxical effects of antidepressant medications. Clinical evidence has been found indicating that even though antidepressant drugs are effective in treating depressive episodes, they are less efficacious in recurrent depression and in preventing relapse. In some cases, antidepressants have been described inducing adverse events such as withdrawal symptoms at discontinuation, onset of tolerance and resistance phenomena and switch and cycle acceleration in bipolar patients. Unfavorable long-term outcomes and paradoxical effects (depression inducing and symptomatic worsening) have also been reported. All these phenomena may be explained on the basis of the oppositional model of tolerance. Continued drug treatment may recruit processes that oppose the initial acute effect of a drug. When drug treatment ends, these processes may operate unopposed, at least for some time and increase vulnerability to relapse. Antidepressant drugs are crucial in the treatment of major depressive episodes. However, appraisal and testing of the oppositional model of tolerance may yield important insights as to long-term treatment and achievement of enduring effects.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728491     DOI: 10.1016/j.pnpbp.2010.07.026

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  31 in total

1.  Meta-analyses and conflict of interest.

Authors:  Giovanni A Fava
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

2.  Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder.

Authors:  Aimee M Hunter; Ian A Cook; Molly Tartter; Simi K Sharma; Gregory D Disse; Andrew F Leuchter
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

3.  Emerging clinical trends and perspectives on comorbid patterns of mental disorders in research.

Authors:  Giovanni A Fava; Eliana Tossani; Per Bech; Carmen Berrocal; Guy Chouinard; Claudio Csillag; Hans-Ulrich Wittchen; Winfried Rief
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

Review 4.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

5.  The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?

Authors:  Jason Yanofski
Journal:  Innov Clin Neurosci       Date:  2011-01

6.  Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs.

Authors:  Emanuela Offidani; Giovanni A Fava; Nicoletta Sonino
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

Review 7.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

Review 8.  Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs.

Authors:  Bryan B Shapiro
Journal:  Psychopharmacology (Berl)       Date:  2018-08-10       Impact factor: 4.530

9.  Are antidepressants effective in the acute and long-term treatment of depression? Sic et Non.

Authors:  Ronald Pies
Journal:  Innov Clin Neurosci       Date:  2012-05

10.  Road to nowhere.

Authors:  Giovanni A Fava
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.